Skip to main content

Table 4 Immunoexpression of the ZNF 281, stratified according to histopathological type, clinical stage, histological grade of ovarian tumors and menopausal status of the study patients (“other” corresponds to stage IB and higher clinical stages of ovarian tumors)

From: Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

ZNF 281 Group Arithmetic mean Standard deviation Minimum Lower quartile Median Upper quartile Maximum Mann-Whitney
U-test
Histopathological type Borderline 3.13 2.36 0.00 2.00 2.50 4.00 8.00 H = 4.4292
p = 0.3510
Clarocellulare 3.70 2.71 0.00 3.00 3.50 4.00 8.00
Endometrioidales 3.13 2.36 0.00 2.00 2.50 4.00 8.00
Mucinosum 4.00 0.00 4.00 4.00 4.00 4.00 4.00
Serosum 4.23 1.83 2.00 4.00 4.00 4.00 8.00
Stage IA 3.45 2.03 0.00 2.00 4.00 4.00 8.00 Z = 0.7566
p = 0.4493
Other 4.15 2.48 0.00 3.00 4.00 4.00 8.00
Grade G1 4.38 1.51 3.00 4.00 4.00 4.00 8.00 Z = 1.3584
p = 0.1743
G2 3.62 2.30 0.00 2.00 4.00 4.00 8.00
Menopausal status Postmenopausal 3.38 1.82 0.00 2.00 4.00 4.00 8.00 Z = 0.5567
p = 0.5777
Premenopausal 4.31 2.78 0.00 2.00 4.00 8.00 8.00